A narrative review of hydrogen therapy for COPD: aging-related insights.
Ya-Ting Chuang, Chun Tseng, Tao-An Chen · Open medicine (Warsaw, Poland) · 2026
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In participants, clinical findings demonstrated improved arterial blood gases, acid-base balance, and exercise tolerance in elderly COPD patients. These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence inflammatory regulation.
What the Findings Mean
H2HUBB reviewed how hydrogen-rich water was evaluated in this publication and summarizes the source-grounded findings below. Clinical findings demonstrated improved arterial blood gases, acid-base balance, and exercise tolerance in elderly COPD patients.
What the Researchers Studied
The study used a narrative review.
What Effects Did Molecular Hydrogen Have?
Clinical findings demonstrated improved arterial blood gases, acid-base balance, and exercise tolerance in elderly COPD patients. Molecular hydrogen (H₂) exhibits selective antioxidant, anti-inflammatory, and anti-senescence properties that may provide therapeutic benefits for chronic obstructive pulmonary disease (COPD), particularly in aging populations where oxidative stress and chronic inflammation are prominent. Given the increasing burden of aging-related COPD and the emerging biological effects of molecular hydrogen, the researchers hypothesized that H₂ therapy may exert beneficial effects by modulating oxidative stress, inflammation, and aging pathways.
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence inflammatory regulation and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a narrative review. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as human clinical study with human clinical evidence. The reported sample size was 20. The study used a narrative review. The hydrogen delivery method was hydrogen-rich water.
Limitations and Safety
Reported limitations: Second, the clinical evidence was based on relatively small sample sizes and short intervention durations, with uncertainties regarding optimal dosing and treatment protocols. Nevertheless, the current evidence base remains limited by small sample sizes and short intervention durations.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.